Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT02659202
Eligibility Criteria:
Inclusion Criteria, includes:
* Heart Failure patients with reduced ejection fraction:
* History of ischemic or idiopathic dilated cardiomyopathy (duration \> 1yr.) stable for \> 3mo and New York Heart Association Class I-III
* Not pacemaker dependent
* Body Mass Index ≤35
* Ejection Fraction \< 40%
* Current nonsmokers with \< 15 pack year history
* Able to exercise
Exclusion Criteria includes:
* History of cardiopulmonary disorders and dangerous arrhythmias
* Pregnant women
* Taking prescribed opioid medications or have had a fusion or laminectomy at L3 or above
* Patients with a recent drug-eluding stent
* History of spinal stenosis, lumbar radiculopathy, or peripheral neuropathy
* Must not currently be taking blood thinners or anticoagulant medications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT02659202
Study Brief:
Protocol Section:
NCT02659202